Prospective phase II trial of nimotuzumab in combination with radiotherapy and concurrent capecitabine in locally advanced rectal cancer.
about
High-dose nimotuzumab improves the survival rate of esophageal cancer patients who underwent radiotherapy.Nimotuzumab combined with concurrent chemoradiotherapy in locally advanced nasopharyngeal carcinoma: a retrospective analysis.Nimotuzumab Combined with Chemotherapy is a Promising Treatment for Locally Advanced and Metastatic Esophageal Cancer.Immunotherapy for the treatment of colorectal tumors: focus on approved and in-clinical-trial monoclonal antibodies.Safety and efficacy of nimotuzumab combined with chemoradiotherapy in Chinese patients with locally advanced cervical cancer.The efficacy of adding targeted agents to neoadjuvant therapy for locally advanced rectal cancer patients: a meta-analysis.
P2860
Prospective phase II trial of nimotuzumab in combination with radiotherapy and concurrent capecitabine in locally advanced rectal cancer.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh-hant
name
Prospective phase II trial of ...... ocally advanced rectal cancer.
@en
Prospective phase II trial of ...... ocally advanced rectal cancer.
@nl
type
label
Prospective phase II trial of ...... ocally advanced rectal cancer.
@en
Prospective phase II trial of ...... ocally advanced rectal cancer.
@nl
prefLabel
Prospective phase II trial of ...... ocally advanced rectal cancer.
@en
Prospective phase II trial of ...... ocally advanced rectal cancer.
@nl
P2093
P2860
P1476
Prospective phase II trial of ...... ocally advanced rectal cancer.
@en
P2093
De-Chuan Li
Hai-Xin Ju
Hai-Yang Feng
Jia-Lin Luo
Lu-Ying Liu
Yong-Tian Fan
Yu-Ping Zhu
P2860
P2888
P304
P356
10.1007/S00384-014-2097-2
P577
2015-01-08T00:00:00Z